Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
93.00    0.00 (0.00%)
Bid:
91.00
Ask:
95.00
Spread: 4.00 (4.396%)
Market Cap: £62.39m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding

22 Aug 2016 15:23

ECO Animal Health Group plc ("ECO" or the "Company")

Director/PDMR Shareholding and Notification

The Company, LEI NO: 01818170 was notified today by the following Directors of the Company of the exercise and subsequent sale on the London Stock Exchange, ISIN: GB0032036807, of 255,000 options, all at a price of £4.40,,at a cost of £2.26 per Ordinary Share of 5 pence each in the Company ("Ordinary Share"), being Ordinary Shares granted as unapproved share options under the Executive Share Option Scheme.

Director Position Holding pre option exercise and share sale Options exercised and then sold Options cost (pence) per Ordinary Share Options held post option exercise and share sale Ordinary share holding post option exercise and share sale %
Marc

Loomes

Executive Director 1,165,000 135,000 226p 1,030,000 .NIL
Brett

Clemo

Executive Director 755,000 75,000 226p 680,000 NIL
Julia

Trouse

Executive Director 347,500 45,000 226p 302,500 NIL

Following these transactions, the Company’s issued ordinary share capital consists of 64,694,406 Ordinary Shares, Each Ordinary Share carries one vote. Accordingly, the number of Ordinary Shares with voting rights in issue is 64,694,406.

PDMR notification
1 Details of the Restricted Person/person closely associated with him or her
a) Name: Marc Loomes Brett Clemo Julia Trouse
2 Reason for the notification
a) Position/Status CEO Executive Director Executive Director
b) Initial notification/ Amendment Initial notification Initial notification Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: ECO Animal Health Group plc
b) LEI 01818170
4 Details of the transaction(s): section to be repeated for (i)each type of instrument: (ii) each type of transaction: (iii) each date: and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
b) Nature of transaction Exercise of options and sale of ordinary shares
c) Prices and volumes Volume exercised 135,0000 ordinary shares 75,0000 ordinary shares 45,0000 ordinary shares
Price aggregate £2.26 Price aggregate £2.26 Price aggregate £2.26
Volume sold 135,000 Ordinary shares Volume sold 75,000 Ordinary shares Volume sold 45,000 Ordinary shares
Price per Ordinary share £4.40 Price per Ordinary share £4.40 Price per Ordinary share £4.40
d) Aggregate information Volume 135,000 Ordinary Shares Volume 75,000 Ordinary Shares Volume 45,000 Ordinary Shares
Aggregate volume and price Price £4.40 per Ordinary Share Price £4.40 per Ordinary Share Price £4.40 per Ordinary Share
e) Date of transaction 22/08/2016 GMT 22/08/2016 GMT 22/08/2016 GMT
f) Place of the transaction London Stock Exchange (XLON) AIM market

Enquiries

ECO Animal Health Group plc

Peter Lawrence, Executive Chairman 020 8336 6190

Marc Loomes, CEO 020 8447 8899

Spiro Financial

Anthony Spiro 020 8336 6196

Peel Hunt LLP (Nominated Adviser)

Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900

View source version on businesswire.com: http://www.businesswire.com/news/home/20160822005615/en/

Copyright Business Wire 2016

Date   Source Headline
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase
9th Oct 20247:00 amRNSIssue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.